Investing Profile

Ed Mathers

VCInvestor

General Partner at New Enterprise Associates (NEA)

Photo of Ed Mathers, General Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
New Enterprise Associates (NEA) Network
32 CONNECTIONS
New Enterprise Associates Network
14 CONNECTIONS
cb
$50K - $50.0M
$25.0M
36
$5B
CompanyStageDateRound SizeTotal Raised
Splice Bio
Series AFeb 2022€50M
€50M
Co-investors: Joël Jean-Mairet (Ysios Capital), Beat Steffen (Novartis Venture Fund), Sylvain Sachot (Asabys Partners)
Affinia Therapeutics
Series BMay 2021$110M
Series AMar 2020$60M
$170M
Co-investors: Robert Weisskoff (F-Prime Capital Partners)
Code Biotherapeutics
Seed RoundApr 2021$10M
$10M
Co-investors: Victor Stone (Takeda Ventures)
Sentry
Series DFeb 2021$60M
Series CSep 2019$40M
$130M
Co-investors: Daniel Levine (Accel), Chetan Puttagunta (Benchmark), Jay Simons (Bond), Ilya Sukhar (Matrix Partners)
MBX Biosciences
Series AJul 2020$35M
$35M
Co-investors: Carl Gordon (OrbiMed), Patrick Heron (Frazier Healthcare Partners)
Shape Therapeutics
Series ANov 2019$36M
$36M
Reneo Pharmaceuticals
Series AMay 2019$50M
$150M
Co-investors: Bali Muralidhar (Abingworth), Niall O’Donnell (RiverVest)
Curzion Pharmaceuticals
Venture RoundJan 2019
Partner New Enterprise Associates (NEA)Present
Partner New Enterprise Associates2008 - Present
NC State University Bachelor of Science (BS)